Recent advances in caspase-3, breast cancer, and traditional Chinese medicine: a review

J Chemother. 2024 Sep;36(5):370-388. doi: 10.1080/1120009X.2023.2278014. Epub 2023 Nov 7.

Abstract

Caspases (cysteinyl aspartate-specific proteinases) are a group of structurally similar proteases in the cytoplasm that can be involved in cell differentiation, programmed death, proliferation, and inflammatory generation. Experts have found that caspase-3 can serve as a terminal splicing enzyme in apoptosis and participate in the mechanism by which cytotoxic drugs kill cancer cells. Breast cancer (BC) has become the most common cancer among women worldwide, posing a severe threat to their lives. Finding new therapeutic targets for BC is the primary task of contemporary physicians. Numerous studies have revealed the close association between caspase-3 expression and BC. Caspase-3 is essential in BC's occurrence, invasion, and metastasis. In addition, Caspase-3 exerts anticancer effects by regulating cell death mechanisms. Traditional Chinese medicine acting through caspase-3 expression is increasingly used in clinical treatment. This review summarizes the biological mechanism of caspase-3 and research progress on BC. It introduces a variety of traditional Chinese medicine related to caspase-3 to provide new ideas for the clinical treatment of BC.

Keywords: Breast cancer; apoptosis; caspase-3; gSDME; programmed cell death; pyroptosis; triple-negative breast cancer.

Publication types

  • Review

MeSH terms

  • Apoptosis* / drug effects
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / pathology
  • Caspase 3* / metabolism
  • Drugs, Chinese Herbal / pharmacology
  • Drugs, Chinese Herbal / therapeutic use
  • Female
  • Humans
  • Medicine, Chinese Traditional*

Substances

  • Caspase 3
  • Drugs, Chinese Herbal
  • CASP3 protein, human